In this webinar, we will explore agentic AI—the next evolution of artificial intelligence systems that can autonomously plan, make decisions, and take action to achieve defined goals. We will discuss how agentic AI differs from today’s reactive, prompt‑driven models, the core capabilities that enable autonomy (planning, tool use, memory, and feedback loops), and real‑world use cases across business, research, and clinical development. The webinar will also cover the opportunities agentic AI creates for productivity and scale, alongside the critical challenges of governance, trust, risk management, and human oversight that life science organizations must address as these systems move from experimentation to deployment.

Disclaimer: This event may be recorded, and your image and/or voice may be included in that recording. If you are uncomfortable, please be sure to turn off your webcam.  

Speaker Bios

Kamayani Gupta, Co-Founder of KAMI Think Tank, Moderator

Kamayani is the co-founder of KAMI Think Tank, an AI research organization in the healthcare life sciences. She has been in the life sciences area for the past 14 years and uses data-centric approaches to optimize complex business processes. Over the past decade, she has enjoyed working with new technologies to reduce redundant workflows and biases in the drug discovery to commercialization pipeline. She was one of the first members of Watson for Drug Discovery and the former Head of HCLS R&D at Slalom.

Junchi Lu, Associate Director at Bristol Myers Squibb

Junchi is an Associate Director at Bristol Myers Squibb, where she architects AI and advanced analytics solutions across the Global Supply Chain — spanning network supply AI agents, predictive risk assessment, and clinical supply forecasting. As a hybrid professional at the intersection of data science, supply chain strategy, and patient impact, she specializes in solving the problems no single function can solve alone: the ones that arise when moving life-saving products from development to patients. Her career reflects a deliberate journey across science, technology, and business. A PhD in electrical engineering from Notre Dame, where her nanophotonics research pioneered infrared medical devices, gave her the technical rigor to work at the limits of hard problems. Years in life sciences strategy consulting and incubator environments sharpened the market instincts that now define her approach to AI deployment in large pharma. Recognized with BMS's Business Insights &Technology Innovation Award, Junchi and her cross-functional team drove measurable business value through AI-enabled supply chain analytics — bridging clinical, commercial, and operations stakeholders around a shared strategic vision. She leads Sino-American Pharmaceutical Professionals Association (SAPA)'s Global Communication team, has hosted 30+ episodes of the SAPA 8@8 career series, and delivered 10+ AI workshops helping practitioners cultivate their "Edge" collaboration.

Stephanie Oestreich, Managing Director of the Myeloma Investment Fund, Moderator

Stephanie is Managing Director of the Myeloma Investment Fund (MIF) and is the chair of the McCloy Alumni Association. She is also on the faculty of MIT, a member of SpringBoard Ventures, an advisor at grIP Venture Studio, to Biognosys (a Bruker company), Invitris, the CART company CelineTx, and to the drug development and investment company OrangeGrove Bio. Previously, she was Chief Business Officer at Galecto, Vice President at cell therapy company Mnemo Therapeutics, a Venture Partner at RA Capital, and Executive Vice President at Evotec, where she built its North American investment arm and started an incubator with Samsara BioCapital. She also worked as an international business leader at F. Roche Hoffmann-La Roche Ltd. and for Novartis in business development and commercial. Stephanie conducted the research for her PhD in biochemistry in the lab of a Nobel Prize winner at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.

Yogita Parulekar, Founder & CEO at Invi Grid Inc.

Yogita has more than two decades of experience in technology risk and cybersecurity. She has been head of security & IT, and a cybersecurity leader at an AI, a healthtech, and a fraud risk tech company, as well as at Oracle and EY. She is a recognized thought leader in the security governance space and an evangelist for security & privacy-by-design principles that ensure systems are built in a way that wins the trust and confidence of their potential customers. She has been recognized in Power 100 2025 by Silicon Valley Business Journal (Innovation category), as a Security Veteran by SC Magazine, 150 women fighting cybercrime by CyberCrime Magazine, and for her contributions as President of ISACA Silicon Valley. She is an eminent speaker at various professional forums, including the Private Directors Association, Expogestion2025 Peru, ITAA-NASSCOM US India cyber summit, ISSA, ISACA, and many others, including as a keynote speaker. Currently, she is the CEO of Invi Grid Inc., which has been recognized as cutting-edge innovation by the Globee awards, Best in the Cloud Governance category, AI Breakthrough awards in the AI safety, security, and compliance category; Global Excellence awards in the Cloud Infrastructure category, and many other recognitions by Cyber Defense Magazine and other media. She is also an investor and a mentor to other founders.

Giselle Ventura

Giselle is an interdisciplinary scientist-engineer working at the intersection of agentic AI and life sciences. She is completing her Master of Science in Data Science at Tufts University, where her thesis focuses on building multi-agent AI systems that autonomously query and synthesize insights across biological databases to accelerate drug target identification and pathway analysis. Her work directly addresses one of modern biology's core bottlenecks: the widening gap between the rate of data generation and the human capacity to interpret it. Before pivoting to AI, Giselle spent five years as a biomedical engineer at Charles Draper Laboratory, developing a pediatric heart valve in close collaboration with physicians at Boston Children's Hospital and Seattle Children's Hospital. That work produced three peer-reviewed publications, including a first-author paper in a 2026 Science Advances publication on a growth-adaptive pediatric heart valve stent. She holds a Master of Engineering from Boston University and a Bachelor of Arts in Neurological Sciences from Cornell University. Giselle also leads the biotech channel at Women Applying AI and organizes in-person events connecting AI practitioners with life science professionals.

Olivia Viessmann, Senior Research Scientist at NVIDIA

Olivia works at the intersection of life sciences, machine learning, and high-performance computing. As a Senior Researcher at NVIDIA, she develops novel AI algorithms to enable life science applications. She previously served as a Principal AI Scientist at Flagship Pioneering, where she designed AI strategies and model development for emerging biotech startups. Olivia holds a PhD in neuroscience from Oxford University, an MSc in physics from Imperial College London, and a BSc in physics from Heidelberg University.

Violet Wittig, Director of Healthcare & Life Sciences Sales at Cloudera

Violet is the Director of Healthcare & Life Sciences Sales at Cloudera, where she leads strategic engagements with enterprise organizations focused on unlocking the value of data through AI and agentic AI solutions. With more than 15 years of experience across healthcare, life sciences, financial services, and media, she is known for helping complex organizations translate advanced technology into measurable business outcomes. Earlier in her career at IBM, Violet partnered closely with Wall Street clients to deliver enterprise-grade data center, security, and analytics solutions—experience that shaped her ability to operate at the intersection of scale, security, and mission-critical data. Over the past 8–9 years, she has focused deeply on healthcare and life sciences, culminating in her recent promotion to Director, where she now dedicates her efforts exclusively to this industry. In her current role, Violet works with industry leaders to drive adoption of a unified data and AI platform that supports agentic AI, data lineage, governance, cataloging, and cybersecurity across cloud and on-premises environments. Her approach centers on building trusted data ecosystems that accelerate time to insight while meeting the rigorous regulatory and security demands of healthcare and life sciences organizations. Adept in strategic selling and executive-level engagement, Violet is a trusted advisor to C-suite leaders, known for aligning stakeholders and helping organizations clearly articulate value at the board level. She is passionate about equipping teams with the tools, frameworks, and confidence needed to turn bold AI visions into boardroom-ready wins.

Pricing Information

• Members/Guests: Free
• Non-Members*: $10

*Not a Member? Click here to learn about the benefits of a WIB Membership — access to our video library, mentorship groups, and more. 

Please read WIB's Code of Conduct and Refund Policy.

Note: The Zoom meeting link will be sent along with a confirmation email after registration has been completed.